QA: Abbvie Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2026_Abbvie_Inc.pdf

Logs

Graph

Absolute values for 0001551152, Abbvie Inc

  xvar xval
0 AssetsCurrent 29,062,000,000
1 IntangibleAssetsNetIncludingGoodwill 88,281,000,000
2 PropertyPlantAndEquipmentNet 5,628,000,000
3 remainder_Assets 10,989,000,000
4 LiabilitiesCurrent 43,289,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 18,175,981,773
8 SellingGeneralAndAdministrativeExpense 13,981,802,464
9 ResearchAndDevelopmentExpense 14,347,517,363
10 remainder_Expenses 1,848,575,492
11 remainder_Revenues 63,230,393,588
12 remainder_NetIncome -8,058,860,951
13 remainder_ComprehensiveNetIncome 619,026,393
  yvar yval
0 Assets 133,960,000,000
1 Liabilities 43,289,000,000
2 Expenses 48,353,877,092
3 Revenues 63,230,393,588
4 StockholdersEquity 90,671,000,000
5 NetIncome 6,817,655,545
6 ComprehensiveNetIncome 7,127,168,742
7 BaseVar 148,755,579,012
8 EconomicCapitalRatiobeforeLimitedLiability 2.31
9 EconomicCapitalRatio 3.23

Edgar->Model Mapping

Feature Distribution

Change over Time